| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 202.1 | 197.2 | 198.1 |
| Other income | -1.3 | 1.8 | 1.4 |
| Total income | 200.9 | 199.0 | 199.5 |
| Profit before exceptional items & tax | 15.5 | 17.8 | 17.3 |
| Profit before tax | 15.5 | 17.8 | 17.3 |
| Net profit | 11.7 | 13.5 | 12.5 |
| Operating margin | 7.7% | 8.9% | 8.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -6.40% |
|---|---|
| Net profit, quarter on quarter | -13.30% |
| Revenue, year on year | +2.00% |
NSE results filing, NSE: ANUHPHR. Figures extracted from the filing.
Anuh Pharma Ltd: key numbers
- Share price
- ₹86.09
- Market cap
- ₹862.8 Cr
- Revenue (annual)
- ₹771.7 Cr
- Net profit (annual)
- ₹41.05 Cr
- P/E (TTM)
- 19.5×Sector 47.4×
- Promoter holding
- 71.80%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anuh Pharma Ltd
All →Anuh Pharma Legal & Regulatory
Anuh Pharma disclosed a Rs. 9,93,206 tax demand under Section 156, Income Tax Act, for AY 2018-19. The company plans to appeal before the CIT.
- Value
- ₹0.10 Cr
Anuh Pharma Investor Presentation: Key Takeaways
Anuh Pharma reported strong Q1 FY27 results with 4% YoY revenue growth and 38% PAT growth, driven by a shift to high-value regulated markets.
- Call
- Guides 18% growth
Anuh Pharma Management Change
Anuh Pharma announced the re-appointment of directors Arun Lalchand Todarwal and Bipin N. Shah, and the appointment of Ankit Kishor Chande as Cost Auditor.
Anuh Pharma Annual General Meeting
Anuh Pharma Ltd held its 66th Annual General Meeting on August 12, 2026. The meeting covered the adoption of financial statements, dividend declaration, and director appointments.
Anuh Pharma Other Announcement
Anuh Pharma Ltd. promoters withdrew their application for reclassification from 'Promoter Group' to 'Public' category. They will continue to remain part of the Promoter Group.
Anuh Pharma Q1 FY27 Results: Net Profit ₹11.4 Cr, Up 37.3% YoY
Anuh Pharma Ltd reported revenue from operations of ₹193.8 Cr (+3.9% YoY) and net profit of ₹11.4 Cr (+37.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹11.4 Cr · +37.3% YoY